Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)

by Guntram Schernthaner
Published 2021-07-01

The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?

by Leszek Czupryniak, Dror Dicker, Roger Lehmann, Martin Prázný, Guntram Schernthaner
Published 2021-10-01

Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures

by Johanna Maria Brix, Hans-Peter Kopp, Florian Höllerl, Gerit Holger Schernthaner, Bernhard Ludvik, Guntram Schernthaner
Published 2019-06-01

Renal Function but Not Asymmetric Dimethylarginine Is Independently Associated with Retinopathy in Type 2 Diabetes

by Katarzyna Krzyzanowska, Friedrich Mittermayer, Gerit H. Schernthaner, Simon Brunner, Johanna M. Brix, Stefan Aschauer, Florian Höllerl, Michael Wolzt, Guntram Schernthaner
Published 2011-01-01

Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly.

by Julia Szendroedi, Elisabeth Zwettler, Albrecht Ingo Schmid, Marek Chmelik, Giovanni Pacini, Gertrud Kacerovsky, Gerhard Smekal, Peter Nowotny, Oswald Wagner, Christoph Schnack, Guntram Schernthaner, Klaus Klaushofer, Michael Roden
Published 2008-01-01

Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)

by Guntram Schernthaner, Roger Lehmann, Martin Prázný, Leszek Czupryniak, Kristine Ducena, Peter Fasching, Andrej Janež, Avraham Karasik, Peter Kempler, Emil Martinka, Marina V. Shestakova, Lea Smirčić Duvnjak, Tsvetalina Tankova
Published 2017-10-01

SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class

by Guntram Schernthaner, Heinz Drexel, Evgeny Moshkovich, Birute Zilaitiene, Emil Martinka, Leszek Czupryniak, Tamás Várkonyi, Andrej Janež, Kristine Ducena, Katarina Lalić, Tsvetalina Tankova, Martin Prázný, Lea Smirčić Duvnjak, Olga Sukhareva, Harald Sourij
Published 2019-06-01

Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs

by Guntram Schernthaner, Avraham Karasik, Agnė Abraitienė, Alexander S. Ametov, Zsolt Gaàl, Janusz Gumprecht, Andrej Janež, Susanne Kaser, Katarina Lalić, Boris N. Mankovsky, Evgeny Moshkovich, Marju Past, Martin Prázný, Gabriela Radulian, Lea Smirčić Duvnjak, Ivan Tkáč, Kārlis Trušinskis
Published 2019-08-01

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

by Guntram Schernthaner, Naim Shehadeh, Alexander S. Ametov, Anna V. Bazarova, Fahim Ebrahimi, Peter Fasching, Andrej Janež, Péter Kempler, Ilze Konrāde, Nebojša M. Lalić, Boris Mankovsky, Emil Martinka, Dario Rahelić, Cristian Serafinceanu, Jan Škrha, Tsvetalina Tankova, Žydrūnė Visockienė
Published 2020-10-01

Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?

by Guntram Schernthaner, Chaim Lotan, Elina Baltadzhieva-Trendafilova, Jonas Ceponis, Martin Clodi, Kristine Ducena, Eva Goncalvesova, Cristian Guja, Marek Honka, Andrej Janež, Nebojša Lalić, Roger Lehmann, Noémi Nyolczas, Priit Pauklin, Andrzej Rynkiewicz, Igor Sergienko, Lea Smirčić Duvnjak
Published 2018-11-01